Document is current

Any future updates will be listed below

762 STING agonism combined with arginase, NOS2, and PTGES/COX2 inhibitors for improved anti-tumor immunotherapeutic benefit

Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.762

Published Online: 2021-11-10

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark